Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gromwell refers to the medicinal root extract of *Lithospermum erythrorhizon* (and related species like *L. officinale*), a traditional herb widely utilized in East Asian medicine. The primary bioactive constituents are naphthoquinone derivatives, most notably **shikonin** and its esters (such as acetylshikonin), along with **lithospermic acid**. Gromwell is traditionally valued for its anti-inflammatory, antimicrobial, and wound-healing properties, often formulated as a topical ointment (**Zicao Gao**) or oil for burns, ulcers, and inflammatory skin conditions. Modern research has expanded its potential applications to include the mitigation of sarcopenia (age-related muscle loss) via the Akt/mTOR pathway, the treatment of intestinal colic, and the development of tubulin-targeted anticancer therapies. It is also investigated for its antioxidant effects mediated through Nrf2 activation and its ability to alleviate menopausal symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gromwell.